CCI |
chronic nerve constriction injury |
DMEM |
Dulbecco’s Modified Eagle’s Medium |
DMEM-Adv |
Dulbecco’s Modified Eagle’s Medium Advance |
ERb |
epidermal receptor beta |
EMA |
European Medicines Agency |
FBS |
foetal bovine serum |
FDA |
Food and Drug Administration |
GGF |
glial growth factor 2 |
HS |
horse serum |
MEM |
Minimum Essential Medium |
MPZ |
myelin protein zero |
NP |
neuropathic pain |
Nrf2 |
nuclear factor erythroid 2-related factor 2 |
Papp |
apparent permeability coefficient |
PCPA |
P-chlorophenylalanine |
PEA |
palmitoylethanolamide |
ROS |
reactive oxygen species |
RPMI-Adv |
Roswell Park Memorial Institute-1640 Advance |
SOD |
superoxide dismutase |
TJ |
tight junction |
TEER |
transepithelial electrical resistance |
TNFα |
tumor necrosis factor α |
6-OHDA |
6-hydroxydopamine |
ZO-1 |
Zonula occludens-1 |